首页 > 最新文献

Osteoarthritis and Cartilage最新文献

英文 中文
Disparities in incident osteoarthritis between sexual minority and heterosexual adults: Findings from a large cohort study 性少数和异性恋成人骨关节炎发病率的差异:来自一项大型队列研究的发现。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-10-10 DOI: 10.1016/j.joca.2025.10.001
Tingting Sha , Yilun Wang , Yuqing Zhang , Jian Zhang , Cong Lu , Jie Wei , Guanghua Lei , Chao Zeng

Objective

Sexual minorities, including lesbian, gay, and bisexual individuals, experience persistent health disparities due to chronic exposure to minority stressors; however, its relation to osteoarthritis (OA) risk remains unexplored. This study aims to investigate the association between sexual orientation and OA risk and evaluate the mediating effect of health behaviors and psychosocial factors in related disparities.

Methods

We conducted a prospective cohort study of 346,320 UK Biobank participants without OA at baseline (2006–2010), followed through December 2021. Coarsened exact matching was applied to balance age, birth cohort, and ethnicity. Sex-stratified Cox models (using age as the time scale) were used to estimate hazard ratios (HRs) for OA risk. Mediation analyses examined the roles of modifiable factors, including body mass index (BMI), socioeconomic status, lifestyle behaviors, and mental health.

Results

Over a median follow-up of 11.3 years, 40,728 participants developed OA. Both bisexual and lesbian women had a higher OA risk than heterosexual women (adjusted HR: 1.17, 95%CI [confidence interval]: 1.07–1.28 and HR: 1.36, 95%CI: 1.10–1.68, respectively). Mediation analysis identified BMI, Townsend index, smoking, and depression as potential mediators, with mediation proportions ranging from 12.1% to 34.2%. In men, gay individuals had lower OA risk (HR: 0.72, 95%CI: 0.60–0.85), with BMI and education explaining 17.5–18.4% of the reduction; no significant difference was observed for bisexual men.

Conclusion

Sexual orientation is associated with OA risk, with bisexual and lesbian women showing higher risk and gay men lower risk than heterosexuals. These disparities are partially explained by BMI, smoking, depression, and socioeconomic status.
性少数群体,包括女同性恋、男同性恋和双性恋个体,由于长期暴露于少数群体压力源,经历了持续的健康差异;然而,其与骨关节炎(OA)风险的关系尚不清楚。本研究旨在探讨性取向与OA风险的关系,并评估健康行为和心理社会因素在相关差异中的中介作用。方法:我们对346,320名基线(2006-2010年)无OA的英国生物银行参与者进行了一项前瞻性队列研究,随访至2021年12月。采用粗精确匹配来平衡年龄、出生队列和种族。使用性别分层Cox模型(以年龄为时间尺度)来估计OA风险的危险比(hr)。中介分析考察了可改变因素的作用,包括身体质量指数、社会经济地位、生活方式行为和心理健康。结果在中位随访11.3年期间,40,728名参与者发生OA。双性恋和女同性恋女性患OA的风险均高于异性恋女性(校正风险比[HR]: 1.17, 95%CI: 1.07-1.28; HR: 1.36, 95%CI: 1.10-1.68)。中介分析发现BMI、Townsend指数、吸烟和抑郁是潜在的中介因素,中介比例从12.1%到34.2%不等。在男性中,男同性恋者患OA的风险较低(HR: 0.72, 95%CI: 0.60-0.85), BMI和受教育程度可以解释17.5% - 18.4%的降低;在双性恋男性中没有观察到显著差异。结论性取向与OA风险相关,双性恋和女同性恋女性风险较高,男同性恋者风险低于异性恋者。这些差异部分可以用BMI、吸烟、抑郁和社会经济地位来解释。
{"title":"Disparities in incident osteoarthritis between sexual minority and heterosexual adults: Findings from a large cohort study","authors":"Tingting Sha ,&nbsp;Yilun Wang ,&nbsp;Yuqing Zhang ,&nbsp;Jian Zhang ,&nbsp;Cong Lu ,&nbsp;Jie Wei ,&nbsp;Guanghua Lei ,&nbsp;Chao Zeng","doi":"10.1016/j.joca.2025.10.001","DOIUrl":"10.1016/j.joca.2025.10.001","url":null,"abstract":"<div><h3>Objective</h3><div>Sexual minorities, including lesbian, gay, and bisexual individuals, experience persistent health disparities due to chronic exposure to minority stressors; however, its relation to osteoarthritis (OA) risk remains unexplored. This study aims to investigate the association between sexual orientation and OA risk and evaluate the mediating effect of health behaviors and psychosocial factors in related disparities.</div></div><div><h3>Methods</h3><div>We conducted a prospective cohort study of 346,320 UK Biobank participants without OA at baseline (2006–2010), followed through December 2021. Coarsened exact matching was applied to balance age, birth cohort, and ethnicity. Sex-stratified Cox models (using age as the time scale) were used to estimate hazard ratios (HRs) for OA risk. Mediation analyses examined the roles of modifiable factors, including body mass index (BMI), socioeconomic status, lifestyle behaviors, and mental health.</div></div><div><h3>Results</h3><div>Over a median follow-up of 11.3 years, 40,728 participants developed OA. Both bisexual and lesbian women had a higher OA risk than heterosexual women (adjusted HR: 1.17, 95%CI [confidence interval]: 1.07–1.28 and HR: 1.36, 95%CI: 1.10–1.68, respectively). Mediation analysis identified BMI, Townsend index, smoking, and depression as potential mediators, with mediation proportions ranging from 12.1% to 34.2%. In men, gay individuals had lower OA risk (HR: 0.72, 95%CI: 0.60–0.85), with BMI and education explaining 17.5–18.4% of the reduction; no significant difference was observed for bisexual men.</div></div><div><h3>Conclusion</h3><div>Sexual orientation is associated with OA risk, with bisexual and lesbian women showing higher risk and gay men lower risk than heterosexuals. These disparities are partially explained by BMI, smoking, depression, and socioeconomic status.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"34 2","pages":"Pages 271-278"},"PeriodicalIF":9.0,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145277328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loss of peptidergic innervation of the subchondral bone in a murine model of MIA-induced osteoarthritis mia诱导的骨关节炎小鼠模型中软骨下骨多肽神经支配的丧失。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-10-04 DOI: 10.1016/j.joca.2025.09.016
Jason Ivanusic , Wendy Imlach , Jenny Thai , Jacob Bos , Jackson Hart , John-Paul Fuller-Jackson

Objective

In the present study, we aimed to determine how osteoarthritis (OA) affects the morphology and distribution of nociceptive nerve endings in the subchondral bone of animals with mono-iodoacetate (MIA)-induced OA.

Design

We used a modified version of the immunolabeling-enabled imaging of solvent-cleared organs (iDISCO/iDISCO+) protocol to visualize peptidergic (CGRP+) nerve terminal labeling in 3D volumes of subchondral bone around the murine knee joint. Total nerve length, number of branch points, and number of endings were derived from manual filament tracing, and were used to quantify changes in animals with MIA-induced OA vs control animals. Von Frey testing was used to assay pain behavior.

Results

In control animals, peptidergic nerves were distributed extensively throughout the condyles of both the tibia and femur. There was a decrease in innervation of the subchondral bone in animals injected with MIA, relative to those injected with saline (n=4/group, Mann-Whitney U-test, P<0.05), that was more obvious in the tibia (filament length μm, saline mean 47,556 [min. 21,442, max. 86,615], MIA mean 4037 [min. 663, max. 10,813]) than the femur (filament length μm, saline mean 37,321 [min. 31,630, max.44,530], MIA mean 18,665 [min. 8670, max. 31,557]). The extent of pain behavior was associated with decreased innervation in the tibia, but not the femur.

Conclusions

Our findings offer unprecedented 3D insight into the full extent of innervation of subchondral bone around the murine knee joint and indicate that there is a loss of peptidergic innervation in the subchondral bone around knee joints of animals with MIA-induced OA.
目的在本研究中,我们旨在确定骨关节炎(OA)如何影响单碘乙酸(MIA)诱导的骨关节炎(OA)动物软骨下骨伤害神经末梢的形态和分布。我们使用一种改进版本的免疫标记溶剂清除器官成像(iDISCO/iDISCO+)方案来可视化小鼠膝关节周围软骨下骨三维体积中的肽能(CGRP+)神经末端标记。总神经长度、分支点数量和末梢数量由人工丝示踪得出,并用于量化mia诱导OA动物与对照动物的变化。采用Von Frey试验分析疼痛行为。结果在对照动物中,多肽神经广泛分布于胫骨和股骨髁。与生理盐水组相比,MIA组软骨下骨神经支配减少(n=4/组,Mann-Whitney u检验,P<0.05),其中胫骨神经支配减少更为明显(纤维长度,生理盐水平均47556 [min])。21442年,马克斯。86615], MIA平均4037[分钟。663年,马克斯。[10813])比股骨(纤维长度,生理盐水平均值37321 [min。31630年,马克斯。44530], MIA平均18665[分钟。8670年,马克斯。31557])。疼痛行为的程度与胫骨神经支配减少有关,但与股骨神经支配减少无关。结论我们的研究结果为小鼠膝关节周围软骨下骨的神经支配提供了前所未有的三维视角,并表明mia诱导的OA动物膝关节周围软骨下骨的肽能神经支配缺失。
{"title":"Loss of peptidergic innervation of the subchondral bone in a murine model of MIA-induced osteoarthritis","authors":"Jason Ivanusic ,&nbsp;Wendy Imlach ,&nbsp;Jenny Thai ,&nbsp;Jacob Bos ,&nbsp;Jackson Hart ,&nbsp;John-Paul Fuller-Jackson","doi":"10.1016/j.joca.2025.09.016","DOIUrl":"10.1016/j.joca.2025.09.016","url":null,"abstract":"<div><h3>Objective</h3><div>In the present study, we aimed to determine how osteoarthritis (OA) affects the morphology and distribution of nociceptive nerve endings in the subchondral bone of animals with mono-iodoacetate (MIA)-induced OA.</div></div><div><h3>Design</h3><div>We used a modified version of the immunolabeling-enabled imaging of solvent-cleared organs (iDISCO/iDISCO+) protocol to visualize peptidergic (CGRP+) nerve terminal labeling in 3D volumes of subchondral bone around the murine knee joint. Total nerve length, number of branch points, and number of endings were derived from manual filament tracing, and were used to quantify changes in animals with MIA-induced OA vs control animals. Von Frey testing was used to assay pain behavior.</div></div><div><h3>Results</h3><div>In control animals, peptidergic nerves were distributed extensively throughout the condyles of both the tibia and femur. There was a decrease in innervation of the subchondral bone in animals injected with MIA, relative to those injected with saline (n=4/group, Mann-Whitney U-test, P&lt;0.05), that was more obvious in the tibia (filament length μm, saline mean 47,556 [min. 21,442, max. 86,615], MIA mean 4037 [min. 663, max. 10,813]) than the femur (filament length μm, saline mean 37,321 [min. 31,630, max.44,530], MIA mean 18,665 [min. 8670, max. 31,557]). The extent of pain behavior was associated with decreased innervation in the tibia, but not the femur.</div></div><div><h3>Conclusions</h3><div>Our findings offer unprecedented 3D insight into the full extent of innervation of subchondral bone around the murine knee joint and indicate that there is a loss of peptidergic innervation in the subchondral bone around knee joints of animals with MIA-induced OA.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"33 12","pages":"Pages 1419-1429"},"PeriodicalIF":9.0,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145235942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A single intra-articular injection of JTA-004, a combination of human plasma, hyaluronic acid, and clonidine, versus placebo in symptomatic knee osteoarthritis: A Phase 3 trial 单次关节内注射JTA-004,联合人血浆、透明质酸和可乐定,与安慰剂相比,治疗症状性膝骨关节炎:一项3期试验。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-25 DOI: 10.1016/j.joca.2025.09.015
Asger Reinstrup Bihlet , Yves Henrotin , Edith Ming Chu Lau , Peter Alexandersen , Olivier Godeaux , Helene Rovsing , François Rieger , Carole Nicco

Objectives

Intra-articular treatments for osteoarthritis (OA) are limited by their efficacy, safety, or duration of response. JTA-004 is a potential novel treatment for OA for intra-articular (IA) injection, combining hyaluronic acid (HA) and clonidine with human plasma to enhance the effects of HA. The objectives of the trial were to evaluate the efficacy and safety of JTA-004 in participants with symptomatic knee OA, where the primary objective was evaluating the efficacy of JTA-004 in terms of WOMAC pain, compared to placebo.

Design

The trial was a multicenter, Phase 3, randomized, double-blind, placebo- and active-controlled clinical trial, evaluating the efficacy and safety of a single IA injection of JTA-004, compared to saline (primary hypothesis) and an HA-comparator (Synvisc-One®) (secondary hypothesis) in knee OA with a Kellgren-Lawrence grade of 2 or 3. For the secondary hypothesis, non-inferiority of JTA-004 to active comparator by comparing the 2 treatment groups on the mean differences in WOMAC pain with a non-inferiority margin of Δ = 10 mm. Primary efficacy endpoint was the change from baseline in WOMAC pain to Month 3. The main secondary efficacy endpoints included changes from baseline in WOMAC function and stiffness at Months 3 and 6, OMERACT-OARSI responder rates, global assessments, and use of rescue medication. Safety assessments were based on adverse events (AE) reporting, and post-injection vital signs.

Results

A total of 746 participants were randomized, of which 687 (92.1%) completed the trial. The results indicated no significant differences in the primary endpoint between JTA-004 and placebo (LSmean difference: −1.50 mm, 95%CI 5.12; 2.12, p= 0.42) or Synvisc-One® (LSmean difference: 2.40, 95% CI: −1.22; 6.02, p=0.20) nor in either of the efficacy outcomes of the main study population. The safety and tolerability of JTA-004 was good, and there were no differences in the frequency of any of the reported AEs or trial discontinuations between the study groups.

Conclusions

A single IA injection of JTA-004 was not superior to a saline solution (LSmean difference: −1.50 mm, 95%CI 5.12; 2.12, p= 0.42) or Synvisc-One® (LSmean difference: 2.40, 95% CI: −1.22; 6.02, p=0.20) for the treatment of OA symptoms in the overall study population.
目的:骨关节炎(OA)的关节内治疗受到其有效性、安全性或反应持续时间的限制。JTA-004是一种潜在的关节内注射治疗OA的新药物,它将透明质酸(HA)和可乐定与人血浆结合,以增强HA的作用。该试验的目的是评估JTA-004对症状性膝关节炎患者的疗效和安全性,其中主要目的是评估JTA-004与安慰剂相比在WOMAC疼痛方面的疗效。该试验是一项多中心、随机、双盲、安慰剂和主动对照的3期临床试验,评估单次注射JTA-004与生理盐水(主要假设)和ha比较剂(Synvisc-One®)(次要假设)在Kellgren-Lawrence分级为2或3级的膝关节OA中的疗效和安全性。次要假设,JTA-004对活性比较剂的非劣效性,通过比较两个治疗组WOMAC疼痛的平均差异,其非劣效性裕度为Δ = 10 mm。主要疗效终点是WOMAC疼痛从基线到第3个月的变化。主要的次要疗效终点包括第3个月和第6个月时WOMAC功能和僵硬度的基线变化,OMERACT-OARSI反应率,总体评估和使用救援药物。安全性评估基于不良事件(AE)报告和注射后生命体征。结果共纳入746例受试者,其中687例(92.1%)完成试验。结果显示,JTA-004和安慰剂的主要终点(LSmean差:-1.50 mm, 95%CI: - 1.12; 2.12, p= 0.42)或Synvisc-One®(LSmean差:2.40,95%CI: -1.22; 6.02, p=0.20)没有显著差异,主要研究人群的疗效结局也没有显著差异。JTA-004的安全性和耐受性良好,两组间报告的不良反应或试验中断的频率没有差异。结论在整个研究人群中,JTA-004单次IA注射治疗OA症状并不优于生理盐水溶液(LSmean difference: -1.50 mm, 95%CI: - 1.12; 2.12, p= 0.42)或Synvisc-One®(LSmean difference: 2.40, 95%CI: -1.22; 6.02, p=0.20)。
{"title":"A single intra-articular injection of JTA-004, a combination of human plasma, hyaluronic acid, and clonidine, versus placebo in symptomatic knee osteoarthritis: A Phase 3 trial","authors":"Asger Reinstrup Bihlet ,&nbsp;Yves Henrotin ,&nbsp;Edith Ming Chu Lau ,&nbsp;Peter Alexandersen ,&nbsp;Olivier Godeaux ,&nbsp;Helene Rovsing ,&nbsp;François Rieger ,&nbsp;Carole Nicco","doi":"10.1016/j.joca.2025.09.015","DOIUrl":"10.1016/j.joca.2025.09.015","url":null,"abstract":"<div><h3>Objectives</h3><div>Intra-articular treatments for osteoarthritis (OA) are limited by their efficacy, safety, or duration of response. JTA-004 is a potential novel treatment for OA for intra-articular (IA) injection, combining hyaluronic acid (HA) and clonidine with human plasma to enhance the effects of HA. The objectives of the trial were to evaluate the efficacy and safety of JTA-004 in participants with symptomatic knee OA, where the primary objective was evaluating the efficacy of JTA-004 in terms of WOMAC pain, compared to placebo.</div></div><div><h3>Design</h3><div>The trial was a multicenter, Phase 3, randomized, double-blind, placebo- and active-controlled clinical trial, evaluating the efficacy and safety of a single IA injection of JTA-004, compared to saline (primary hypothesis) and an HA-comparator (Synvisc-One®) (secondary hypothesis) in knee OA with a Kellgren-Lawrence grade of 2 or 3. For the secondary hypothesis, non-inferiority of JTA-004 to active comparator by comparing the 2 treatment groups on the mean differences in WOMAC pain with a non-inferiority margin of Δ = 10 mm. Primary efficacy endpoint was the change from baseline in WOMAC pain to Month 3. The main secondary efficacy endpoints included changes from baseline in WOMAC function and stiffness at Months 3 and 6, OMERACT-OARSI responder rates, global assessments, and use of rescue medication. Safety assessments were based on adverse events (AE) reporting, and post-injection vital signs.</div></div><div><h3>Results</h3><div>A total of 746 participants were randomized, of which 687 (92.1%) completed the trial. The results indicated no significant differences in the primary endpoint between JTA-004 and placebo (LSmean difference: −1.50 mm, 95%CI 5.12; 2.12, p= 0.42) or Synvisc-One® (LSmean difference: 2.40, 95% CI: −1.22; 6.02, p=0.20) nor in either of the efficacy outcomes of the main study population. The safety and tolerability of JTA-004 was good, and there were no differences in the frequency of any of the reported AEs or trial discontinuations between the study groups.</div></div><div><h3>Conclusions</h3><div>A single IA injection of JTA-004 was not superior to a saline solution (LSmean difference: −1.50 mm, 95%CI 5.12; 2.12, p= 0.42) or Synvisc-One® (LSmean difference: 2.40, 95% CI: −1.22; 6.02, p=0.20) for the treatment of OA symptoms in the overall study population.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"34 2","pages":"Pages 279-289"},"PeriodicalIF":9.0,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Definitions and reporting of usual care in randomized trials for the treatment of knee osteoarthritis: A scoping review 膝骨关节炎治疗随机试验中常规治疗的定义和报告:一项范围综述。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-24 DOI: 10.1016/j.joca.2025.09.013
Victoria D’Alessandro , Dimitra V. Pouliopoulou , Marjan Saeedi , Joy C. MacDermid , Nicole Billias , Aidan Loh , Jessica J. Wong , Trevor Birmingham , Lauren K. King , Tiago V. Pereira , Bruno R. da Costa , Pavlos Bobos

Objective

“Usual care” is a common comparator in randomized trials (RCTs) evaluating interventions for knee osteoarthritis (OA), but it lacks a standardized definition. This scoping review aimed to systematically map how usual care has been defined and reported in knee OA RCTs, with attention to the terminology, components, and adherence to reporting standards.

Methods

We searched MEDLINE, EMBASE, CENTRAL, CINAHL, and the ClinicalTrials.gov registry from inception to May 2025 for trials involving adults with knee OA that compared a non-surgical intervention to usual care (or similar terms). Paired reviewers independently screened citations and extracted study characteristics, terminology used to describe and components of usual care, care setting, OA severity and diagnosis, intervention type, and references to external guidelines. We summarized findings and assessed reporting quality using the Template for Intervention Description and Replication (TIDieR) and Consensus on Exercise Reporting Template (CERT) checklists, where applicable.

Results

Of 11804 citations screened, we identified 154 RCTs across 33 countries. “Usual care” was the most frequently used descriptor term (53.9%), with definitions that varied considerably. While 68.2% of trials provided detailed descriptions, nearly one-third offered only vague or minimal information. Only 22.7% referenced external guidelines. Usual care content ranged from minimal care to complex multimodal packages, with substantial variation by intervention type. Reporting quality was suboptimal: trials addressed, on average, just over half of TIDieR and approximately two thirds of CERT checklist items. Usual care often lacked transparency, standardization, and reference to best practice recommendations.

Conclusion

One in three knee OA trials using usual care as a comparator did not provide a clear, detailed definition of “usual care.” Variability in usual care definitions and reporting compromise trial validity, limit evidence synthesis, and hinder clinical translation. There is an urgent need for standardization of detailed reporting of usual care interventions in knee OA trials.
目的:在评估膝关节骨关节炎(OA)干预措施的随机试验(rct)中,“常规护理”是一个常见的比较指标,但它缺乏标准化的定义。本综述旨在系统地绘制膝关节OA随机对照试验中常规护理的定义和报告,并关注术语、组成部分和对报告标准的依从性。方法:我们检索MEDLINE、EMBASE、CENTRAL、CINAHL和ClinicalTrials.gov注册表,从成立到2025年5月,对成人膝关节OA患者进行非手术干预与常规护理(或类似术语)比较的试验。配对审稿人独立筛选引文并提取研究特征、用于描述常规护理的术语和组成部分、护理环境、OA严重程度和诊断、干预类型以及对外部指南的参考。在适用的情况下,我们使用干预描述和复制模板(TIDieR)和演习报告模板共识(CERT)核对表总结了研究结果并评估了报告质量。在筛选的11804篇引文中,我们在33个国家中确定了154项随机对照试验。“常规护理”是最常用的描述词(53.9%),其定义差异很大。虽然68.2%的试验提供了详细的描述,但近三分之一的试验只提供了模糊或最少的信息。只有22.7%的人参考了外部指南。常规护理内容从最低限度的护理到复杂的多式联运方案不等,干预类型差异很大。报告质量是次优的:试验平均只处理了TIDieR的一半以上和CERT检查表项目的大约三分之二。常规护理往往缺乏透明度、标准化和对最佳实践建议的参考。结论:三分之一的膝关节OA试验使用常规护理作为对照,没有提供“常规护理”的清晰、详细的定义。常规护理定义和报告的可变性损害了试验的有效性,限制了证据的综合,并阻碍了临床转化。目前迫切需要对膝关节OA试验中常规护理干预措施的详细报告进行标准化。
{"title":"Definitions and reporting of usual care in randomized trials for the treatment of knee osteoarthritis: A scoping review","authors":"Victoria D’Alessandro ,&nbsp;Dimitra V. Pouliopoulou ,&nbsp;Marjan Saeedi ,&nbsp;Joy C. MacDermid ,&nbsp;Nicole Billias ,&nbsp;Aidan Loh ,&nbsp;Jessica J. Wong ,&nbsp;Trevor Birmingham ,&nbsp;Lauren K. King ,&nbsp;Tiago V. Pereira ,&nbsp;Bruno R. da Costa ,&nbsp;Pavlos Bobos","doi":"10.1016/j.joca.2025.09.013","DOIUrl":"10.1016/j.joca.2025.09.013","url":null,"abstract":"<div><h3>Objective</h3><div>“Usual care” is a common comparator in randomized trials (RCTs) evaluating interventions for knee osteoarthritis (OA), but it lacks a standardized definition. This scoping review aimed to systematically map how usual care has been defined and reported in knee OA RCTs, with attention to the terminology, components, and adherence to reporting standards.</div></div><div><h3>Methods</h3><div>We searched MEDLINE, EMBASE, CENTRAL, CINAHL, and the ClinicalTrials.gov registry from inception to May 2025 for trials involving adults with knee OA that compared a non-surgical intervention to usual care (or similar terms). Paired reviewers independently screened citations and extracted study characteristics, terminology used to describe and components of usual care, care setting, OA severity and diagnosis, intervention type, and references to external guidelines. We summarized findings and assessed reporting quality using the Template for Intervention Description and Replication (TIDieR) and Consensus on Exercise Reporting Template (CERT) checklists, where applicable.</div></div><div><h3>Results</h3><div>Of 11804 citations screened, we identified 154 RCTs across 33 countries. “Usual care” was the most frequently used descriptor term (53.9%), with definitions that varied considerably. While 68.2% of trials provided detailed descriptions, nearly one-third offered only vague or minimal information. Only 22.7% referenced external guidelines. Usual care content ranged from minimal care to complex multimodal packages, with substantial variation by intervention type. Reporting quality was suboptimal: trials addressed, on average, just over half of TIDieR and approximately two thirds of CERT checklist items. Usual care often lacked transparency, standardization, and reference to best practice recommendations.</div></div><div><h3>Conclusion</h3><div>One in three knee OA trials using usual care as a comparator did not provide a clear, detailed definition of “usual care.” Variability in usual care definitions and reporting compromise trial validity, limit evidence synthesis, and hinder clinical translation. There is an urgent need for standardization of detailed reporting of usual care interventions in knee OA trials.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"33 12","pages":"Pages 1485-1501"},"PeriodicalIF":9.0,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145153517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilization rates of hip arthroplasty in OECD countries revised 经修订的经合组织国家髋关节置换术使用率。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-19 DOI: 10.1016/j.joca.2025.09.012
Jonas Backes , Christof Pabinger , Harald Lothaller , Alexander Geissler

Objective

In 2014, we reported rising hip arthroplasty utilization across Organization for Economic Co-operation and Development (OECD) countries, particularly among younger patients. Since then, healthcare systems have evolved, demographic shifts are continued, and procedures were impacted by the COVID-19 pandemic. This study aims to reassess these trends through 2022.

Methods

We analyzed hip arthroplasty data from the OECD Health Statistics, U.S. Nationwide Inpatient Sample, and World Bank for 27 countries (2005–2022). We compared relative (compound annual growth rates (CAGR)) and absolute (i.e., mean annual differences (MAD)) procedure numbers, stratified by age (≤64 vs. ≥65), and examined associations with GDP, health expenditure, and life expectancy. Sensitivity analyses were performed to account for uncertainty in U.S. data.

Results

Between 2011 and 2022, hip arthroplasty utilization grew more slowly than 2005–2011 (CAGR: 1.00% vs. 2.03%; MAD: 1.78 vs. 2.03). Growth from 2011 to 2022 was concentrated among patients aged ≤64 (CAGR 3.08%; MAD: 3.11), while utilization declined among those ≥65 (CAGR: −2.27%; MAD: −12.46). Country-level variation narrowed, with the highest-to-lowest ratio falling from 6.65 (2005) to 2.96 (2022). Despite a sharp drop in 2020 due to COVID-19, most countries recovered by 2022. Sensitivity analyses confirmed the robustness of observed OECD trends. BRIC nations showed faster growth, but data limitations hindered comparisons.

Conclusion

Hip arthroplasty utilization continues to increase among younger patients but has declined in older ones. Continued demographic pressure and recovery from COVID-19 disruptions are expected to drive further increases in procedure volume.
目的:2014年,我们报告了经济合作与发展组织(OECD)国家髋关节置换术使用率的上升,尤其是在年轻患者中。自那时以来,卫生保健系统不断发展,人口结构持续变化,程序受到COVID-19大流行的影响。这项研究旨在重新评估到2022年的这些趋势。方法:我们分析了经合组织卫生统计、美国全国住院患者样本和世界银行27个国家(2005-2022年)的髋关节置换术数据。我们比较了相对(复合年增长率(CAGR))和绝对(即平均年差异(MAD))手术数,按年龄(≤64 vs≥65)分层,并检查了与GDP、卫生支出和预期寿命的关系。进行敏感性分析以解释美国数据结果的不确定性。2011年至2022年期间,髋关节置换术使用率的增长速度比2005-2011年慢(复合年增长率1.00%对2.03%;MAD: 1.78对2.03)。从2011年到2022年,增长集中在≤64岁的患者(复合年增长率3.08%,MAD: 3.11),而≥65岁的患者利用率下降(复合年增长率-2.27%,MAD: -12.46)。国家层面的差异缩小,最高与最低比率从6.65(2005年)降至2.96(2022年)。尽管2020年受2019冠状病毒病影响大幅下降,但大多数国家到2022年实现了复苏。敏感性分析证实了观察到的经合组织趋势的稳健性。金砖四国增长较快,但数据限制阻碍了比较。结论年轻患者髋关节置换术使用率持续上升,而老年患者有所下降。持续的人口压力和COVID-19中断后的恢复预计将推动手术量进一步增加。
{"title":"Utilization rates of hip arthroplasty in OECD countries revised","authors":"Jonas Backes ,&nbsp;Christof Pabinger ,&nbsp;Harald Lothaller ,&nbsp;Alexander Geissler","doi":"10.1016/j.joca.2025.09.012","DOIUrl":"10.1016/j.joca.2025.09.012","url":null,"abstract":"<div><h3>Objective</h3><div>In 2014, we reported rising hip arthroplasty utilization across Organization for Economic Co-operation and Development (OECD) countries, particularly among younger patients. Since then, healthcare systems have evolved, demographic shifts are continued, and procedures were impacted by the COVID-19 pandemic. This study aims to reassess these trends through 2022.</div></div><div><h3>Methods</h3><div>We analyzed hip arthroplasty data from the OECD Health Statistics, U.S. Nationwide Inpatient Sample, and World Bank for 27 countries (2005–2022). We compared relative (compound annual growth rates (CAGR)) and absolute (i.e., mean annual differences (MAD)) procedure numbers, stratified by age (≤64 vs. ≥65), and examined associations with GDP, health expenditure, and life expectancy. Sensitivity analyses were performed to account for uncertainty in U.S. data.</div></div><div><h3>Results</h3><div>Between 2011 and 2022, hip arthroplasty utilization grew more slowly than 2005–2011 (CAGR: 1.00% vs. 2.03%; MAD: 1.78 vs. 2.03). Growth from 2011 to 2022 was concentrated among patients aged ≤64 (CAGR 3.08%; MAD: 3.11), while utilization declined among those ≥65 (CAGR: −2.27%; MAD: −12.46). Country-level variation narrowed, with the highest-to-lowest ratio falling from 6.65 (2005) to 2.96 (2022). Despite a sharp drop in 2020 due to COVID-19, most countries recovered by 2022. Sensitivity analyses confirmed the robustness of observed OECD trends. BRIC nations showed faster growth, but data limitations hindered comparisons.</div></div><div><h3>Conclusion</h3><div>Hip arthroplasty utilization continues to increase among younger patients but has declined in older ones. Continued demographic pressure and recovery from COVID-19 disruptions are expected to drive further increases in procedure volume.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"33 12","pages":"Pages 1475-1484"},"PeriodicalIF":9.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcript profiling reveals IL-1β and TGF-β1 regulation of chemokine expression in fibroblast-like synoviocytes. 转录谱分析显示IL-1β和TGF-β1调节成纤维细胞样滑膜细胞趋化因子的表达。
IF 7 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-19 DOI: 10.1016/j.joca.2025.09.011
Lei Cai,Robert H Brophy,Eric D Tycksen,Muhammad Farooq Rai
OBJECTIVEFibroblast-like synoviocytes (FLS) are crucial in maintaining joint homeostasis under normal physiological conditions. However, under inflammatory settings, they release factors contributing to tissue damage and osteoarthritis (OA). This study evaluates FLS as a disease-relevant model by profiling transcriptome-wide responses following IL-1β exposure and assessing whether TGF-β1 can antagonize these responses.DESIGNPrimary FLS from synovial explants of patients undergoing anterior cruciate ligament reconstruction were expanded and exposed to IL-1β (10-ng/mL) for 24h to simulate an inflammatory microenvironment characteristic of OA. Transcriptomic changes were profiled using the Illumina NovaSeq-6000 platform and validated through Fluidigm multiplex digital PCR. To assess the immunomodulatory effects of TGF-β1, FLS were treated with TGF-β1 (10-ng/mL) for 48h following IL-1β exposure, and chemokine gene expression was analyzed by digital PCR.RESULTSIL-1β-treated FLS exhibited marked upregulation of several chemokines (e.g., CCL20, CXCL8) and other arthritis-related genes (CSF2, MMP12, IL1B, LIPM), while downregulation of KRT14, KRT19, KRT18, and other anabolic and cytoskeletal genes. Highly expressed genes were enriched in NFκB, cytokine/chemokine, TNF signaling, and necroptosis/ferroptosis pathways. Notably, TGF-β1 significantly reduced IL-1β-induced chemokines. Mechanistically, this suppression correlated with about a 50% reduction in the expression of NFκB and C/EBPβ transcription factors, suggesting that TGF-β1 mediates anti-chemokine effects in part through transcriptional repression of NFκB and C/EBPβ.CONCLUSIONSIL-1β induces exuberant inflammatory responses in FLS, akin to chondrocytes, highlighting that FLS can effectively model inflammatory OA. Importantly, TGF-β1 emerges as a potent modulator capable of suppressing these responses, positioning it as a potential therapeutic candidate for restoring joint homeostasis.
目的:成纤维细胞样滑膜细胞(FLS)在正常生理条件下维持关节稳态中起着至关重要的作用。然而,在炎症环境下,它们会释放导致组织损伤和骨关节炎(OA)的因子。本研究通过分析IL-1β暴露后的转录组反应,并评估TGF-β1是否能拮抗这些反应,来评估FLS作为一种疾病相关模型。设计将前交叉韧带重建患者滑膜外植体的FLS扩增并暴露于IL-1β (10-ng/mL)中24小时,以模拟OA的炎症微环境特征。转录组学变化使用Illumina NovaSeq-6000平台进行分析,并通过Fluidigm多重数字PCR进行验证。为了评估TGF-β1的免疫调节作用,我们在IL-1β暴露后用TGF-β1 (10-ng/mL)处理FLS 48小时,并通过数字PCR分析趋化因子基因的表达。结果tsil -1β处理的FLS中,几种趋化因子(如CCL20、CXCL8)和其他关节炎相关基因(CSF2、MMP12、IL1B、LIPM)显著上调,KRT14、KRT19、KRT18等合成代谢和细胞骨架基因下调。高表达基因富集于NFκB、细胞因子/趋化因子、TNF信号通路和坏死性死亡/铁性死亡通路。值得注意的是,TGF-β1显著降低il -1β诱导的趋化因子。在机制上,这种抑制与NFκB和C/EBPβ转录因子表达减少约50%相关,表明TGF-β1部分通过转录抑制NFκB和C/EBPβ介导抗趋化因子作用。结论sil -1β在FLS中诱导旺盛的炎症反应,类似于软骨细胞,表明FLS可以有效地模拟炎性OA。重要的是,TGF-β1是一种有效的调节剂,能够抑制这些反应,将其定位为恢复关节稳态的潜在治疗候选物。
{"title":"Transcript profiling reveals IL-1β and TGF-β1 regulation of chemokine expression in fibroblast-like synoviocytes.","authors":"Lei Cai,Robert H Brophy,Eric D Tycksen,Muhammad Farooq Rai","doi":"10.1016/j.joca.2025.09.011","DOIUrl":"https://doi.org/10.1016/j.joca.2025.09.011","url":null,"abstract":"OBJECTIVEFibroblast-like synoviocytes (FLS) are crucial in maintaining joint homeostasis under normal physiological conditions. However, under inflammatory settings, they release factors contributing to tissue damage and osteoarthritis (OA). This study evaluates FLS as a disease-relevant model by profiling transcriptome-wide responses following IL-1β exposure and assessing whether TGF-β1 can antagonize these responses.DESIGNPrimary FLS from synovial explants of patients undergoing anterior cruciate ligament reconstruction were expanded and exposed to IL-1β (10-ng/mL) for 24h to simulate an inflammatory microenvironment characteristic of OA. Transcriptomic changes were profiled using the Illumina NovaSeq-6000 platform and validated through Fluidigm multiplex digital PCR. To assess the immunomodulatory effects of TGF-β1, FLS were treated with TGF-β1 (10-ng/mL) for 48h following IL-1β exposure, and chemokine gene expression was analyzed by digital PCR.RESULTSIL-1β-treated FLS exhibited marked upregulation of several chemokines (e.g., CCL20, CXCL8) and other arthritis-related genes (CSF2, MMP12, IL1B, LIPM), while downregulation of KRT14, KRT19, KRT18, and other anabolic and cytoskeletal genes. Highly expressed genes were enriched in NFκB, cytokine/chemokine, TNF signaling, and necroptosis/ferroptosis pathways. Notably, TGF-β1 significantly reduced IL-1β-induced chemokines. Mechanistically, this suppression correlated with about a 50% reduction in the expression of NFκB and C/EBPβ transcription factors, suggesting that TGF-β1 mediates anti-chemokine effects in part through transcriptional repression of NFκB and C/EBPβ.CONCLUSIONSIL-1β induces exuberant inflammatory responses in FLS, akin to chondrocytes, highlighting that FLS can effectively model inflammatory OA. Importantly, TGF-β1 emerges as a potent modulator capable of suppressing these responses, positioning it as a potential therapeutic candidate for restoring joint homeostasis.","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"17 1","pages":""},"PeriodicalIF":7.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computational translation of mouse models of osteoarthritis predicts human disease. 骨关节炎小鼠模型的计算翻译预测人类疾病。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-19 DOI: 10.1016/j.joca.2025.09.010
Maya R Frost, Brendan K Ball, Meghana Pendyala, Stephen R Douglas, Douglas K Brubaker, Deva D Chan

Objective: Translation of biological insights from preclinical studies to human disease is a pressing challenge in biomedical research, including in osteoarthritis. Translatable Components Regression (TransComp-R) is a computational framework previously used to identify biological pathways predictive of human disease conditions. We aimed to evaluate the translatability of two common murine models of post-traumatic osteoarthritis - surgical destabilization of the medial meniscus (DMM) and noninvasive anterior cruciate ligament rupture (ACLR) - to transcriptomics cartilage data from human osteoarthritis studies.

Method: Publicly available transcriptomics cartilage data from mouse models and human osteoarthritis were analyzed. TransComp-R was used to project human osteoarthritis data into either DMM or ACLR mouse model principal component analysis space. The principal components (PCs) were regressed against human osteoarthritis using increasing complexity of linear regression models incorporating human covariates of sex and age. Biological pathways of the mouse PCs that significantly stratified human osteoarthritis and control groups were then interpreted using Gene Set Enrichment Analysis.

Results: Using TransComp-R, we identified different enriched biological pathways across DMM and ACLR models. Both murine models predicted at least one human study with greater than 50% cumulative variance explained. Translatable DMM PCs revealed pathways associated with inflammation, cell signaling, and metabolism, and translatable ACLR PCs represented immune function and other cellular pathways associated with osteoarthritis.

Conclusions: Both mouse model more successfully predicted osteoarthritis in human studies with controls without a history of joint pathology. Cross-species, covariate-aware translational approaches support the selection of preclinical models intended for therapeutic discovery and pathway analysis in humans.

目的:将临床前研究的生物学见解转化为人类疾病是生物医学研究的一个紧迫挑战,包括骨关节炎。可翻译成分回归(TransComp-R)是一种计算框架,以前用于识别预测人类疾病状况的生物途径。我们的目的是评估两种常见的创伤后骨关节炎小鼠模型——内侧半月板手术不稳定(DMM)和无创前交叉韧带断裂(ACLR)——对人类骨关节炎研究中软骨转录组学数据的可翻译性。方法:对小鼠模型和人骨关节炎的转录组学软骨数据进行分析。使用TransComp-R将人类骨关节炎数据投射到DMM或ACLR小鼠模型主成分分析空间中。主成分(PCs)对人类骨关节炎的回归使用增加复杂性的线性回归模型,包括人类的协变量性别和年龄。然后使用基因集富集分析来解释具有明显人类骨关节炎分层和对照组的小鼠pc的生物学途径。结果:使用TransComp-R,我们在DMM和ACLR模型中发现了不同的富集生物通路。两种小鼠模型预测了至少一项人类研究,解释了大于50%的累积方差。可翻译的DMM pc揭示了与炎症、细胞信号传导和代谢相关的途径,可翻译的ACLR pc代表了与骨关节炎相关的免疫功能和其他细胞途径。结论:这两种小鼠模型在没有关节病理史的对照研究中更成功地预测了骨关节炎。跨物种、协变量感知的翻译方法支持临床前模型的选择,用于人类治疗发现和途径分析。
{"title":"Computational translation of mouse models of osteoarthritis predicts human disease.","authors":"Maya R Frost, Brendan K Ball, Meghana Pendyala, Stephen R Douglas, Douglas K Brubaker, Deva D Chan","doi":"10.1016/j.joca.2025.09.010","DOIUrl":"10.1016/j.joca.2025.09.010","url":null,"abstract":"<p><strong>Objective: </strong>Translation of biological insights from preclinical studies to human disease is a pressing challenge in biomedical research, including in osteoarthritis. Translatable Components Regression (TransComp-R) is a computational framework previously used to identify biological pathways predictive of human disease conditions. We aimed to evaluate the translatability of two common murine models of post-traumatic osteoarthritis - surgical destabilization of the medial meniscus (DMM) and noninvasive anterior cruciate ligament rupture (ACLR) - to transcriptomics cartilage data from human osteoarthritis studies.</p><p><strong>Method: </strong>Publicly available transcriptomics cartilage data from mouse models and human osteoarthritis were analyzed. TransComp-R was used to project human osteoarthritis data into either DMM or ACLR mouse model principal component analysis space. The principal components (PCs) were regressed against human osteoarthritis using increasing complexity of linear regression models incorporating human covariates of sex and age. Biological pathways of the mouse PCs that significantly stratified human osteoarthritis and control groups were then interpreted using Gene Set Enrichment Analysis.</p><p><strong>Results: </strong>Using TransComp-R, we identified different enriched biological pathways across DMM and ACLR models. Both murine models predicted at least one human study with greater than 50% cumulative variance explained. Translatable DMM PCs revealed pathways associated with inflammation, cell signaling, and metabolism, and translatable ACLR PCs represented immune function and other cellular pathways associated with osteoarthritis.</p><p><strong>Conclusions: </strong>Both mouse model more successfully predicted osteoarthritis in human studies with controls without a history of joint pathology. Cross-species, covariate-aware translational approaches support the selection of preclinical models intended for therapeutic discovery and pathway analysis in humans.</p>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12538500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
T2 mapping of the articular cartilage as a biomarker for knee osteoarthritis: An analysis of the population-based Rotterdam Study 关节软骨作为膝骨关节炎生物标志物的T2图谱:基于人群的鹿特丹研究分析
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-18 DOI: 10.1016/j.joca.2025.09.009
Netanja I. Harlianto , Jukka Hirvasniemi , Dirk H.J. Poot , Stefan Klein , Sita M.A. Bierma-Zeinstra , Dieuwke Schiphof , Edwin H.G. Oei

Objective

Only few studies have investigated quantitative magnetic resonance imaging (MRI) T2 mapping of knee cartilage in population-based cohorts. Our objective was to evaluate the association between T2 relaxation times of different cartilage segments and the presence of knee MRI-based osteoarthritis (OA) and patient characteristics in a large population-based cohort.

Design

In this cross-sectional study, we included 673 females (mean age: 59.8 years; standard deviation: 3.7) scanned with 1.5T-MRI from a sub-cohort of the Rotterdam Study. T2 relaxation times were calculated in six femoral and tibial cartilage regions of interest. Associations between T2 relaxation times, MRI Osteoarthritis Knee Score (MOAKS)-based tibiofemoral OA, and Knee injury and Osteoarthritis Outcome Score (KOOS)-based symptom status were evaluated using multivariate fixed effects regression analyses.

Results

A total of 1332 knees were included, of which 237 (17.7%) had MRI-based OA. Patients with OA had higher T2 relaxation times across all cartilage segments, and T2 values positively correlated with BMI (r = 0.17–0.46), the strongest correlations being in the lateral compartment. Weak associations were found between T2 relaxation times and age. After adjustments, T2 values in the lateral weight-bearing femur (OR: 0.67; 95%CI: 0.56–0.79), lateral tibia (OR: 1.11; 95%CI: 1.00–1.24), lateral posterior femur (OR: 1.48; 95%CI: 1.28–1.72), and medial posterior femur (OR: 1.14; 95%CI: 1.01–1.30), were associated with the presence of OA. T2 relaxation times were not associated with the KOOS-based symptom status.

Conclusion

In this population-based cohort, T2 values were associated with BMI. Additionally, T2 values in the lateral cartilage subregions were associated with MRI-based OA.
目的:在以人群为基础的队列中,只有少数研究调查了膝关节软骨的定量磁共振成像(MRI) T2定位。我们的目的是评估不同软骨节段的T2松弛时间与膝关节mri骨关节炎(OA)的存在和患者特征之间的关系。在这项横断面研究中,我们纳入了来自鹿特丹研究亚队列的673名女性(平均年龄:59.8岁,标准差:3.7)的1.5T-MRI扫描。计算6个感兴趣的股骨和胫骨软骨区域的T2松弛时间。使用多变量固定效应回归分析评估T2放松时间、基于MRI骨关节炎膝关节评分(MOAKS)的胫骨股骨OA和基于膝关节损伤和骨关节炎结局评分(oos)的症状状态之间的关联。结果共纳入1332例膝关节,其中237例(17.7%)为mri型OA。骨性关节炎患者所有软骨节段的T2松弛时间均较高,T2值与BMI呈正相关(r = 0.17-0.46),其中外侧间室相关性最强。T2松弛时间与年龄之间存在弱关联。调整后,外侧负重股骨(OR: 0.67; 95%CI: 0.56-0.79)、外侧胫骨(OR: 1.11; 95%CI: 1.00-1.24)、外侧股骨后侧(OR: 1.48; 95%CI: 1.28-1.72)和内侧股骨后侧(OR: 1.14; 95%CI: 1.01-1.30)的T2值与骨关节炎的存在相关。T2松弛时间与koos症状状态无关。结论在这个以人群为基础的队列中,T2值与BMI相关。此外,外侧软骨亚区T2值与基于mri的OA相关。
{"title":"T2 mapping of the articular cartilage as a biomarker for knee osteoarthritis: An analysis of the population-based Rotterdam Study","authors":"Netanja I. Harlianto ,&nbsp;Jukka Hirvasniemi ,&nbsp;Dirk H.J. Poot ,&nbsp;Stefan Klein ,&nbsp;Sita M.A. Bierma-Zeinstra ,&nbsp;Dieuwke Schiphof ,&nbsp;Edwin H.G. Oei","doi":"10.1016/j.joca.2025.09.009","DOIUrl":"10.1016/j.joca.2025.09.009","url":null,"abstract":"<div><h3>Objective</h3><div>Only few studies have investigated quantitative magnetic resonance imaging (MRI) T<sub>2</sub> mapping of knee cartilage in population-based cohorts. Our objective was to evaluate the association between T<sub>2</sub> relaxation times of different cartilage segments and the presence of knee MRI-based osteoarthritis (OA) and patient characteristics in a large population-based cohort.</div></div><div><h3>Design</h3><div>In this cross-sectional study, we included 673 females (mean age: 59.8 years; standard deviation: 3.7) scanned with 1.5T-MRI from a sub-cohort of the Rotterdam Study. T<sub>2</sub> relaxation times were calculated in six femoral and tibial cartilage regions of interest. Associations between T<sub>2</sub> relaxation times, MRI Osteoarthritis Knee Score (MOAKS)-based tibiofemoral OA, and Knee injury and Osteoarthritis Outcome Score (KOOS)-based symptom status were evaluated using multivariate fixed effects regression analyses.</div></div><div><h3>Results</h3><div>A total of 1332 knees were included, of which 237 (17.7%) had MRI-based OA. Patients with OA had higher T<sub>2</sub> relaxation times across all cartilage segments, and T<sub>2</sub> values positively correlated with BMI (r = 0.17–0.46), the strongest correlations being in the lateral compartment. Weak associations were found between T<sub>2</sub> relaxation times and age. After adjustments, T<sub>2</sub> values in the lateral weight-bearing femur (OR: 0.67; 95%CI: 0.56–0.79), lateral tibia (OR: 1.11; 95%CI: 1.00–1.24), lateral posterior femur (OR: 1.48; 95%CI: 1.28–1.72), and medial posterior femur (OR: 1.14; 95%CI: 1.01–1.30), were associated with the presence of OA. T<sub>2</sub> relaxation times were not associated with the KOOS-based symptom status.</div></div><div><h3>Conclusion</h3><div>In this population-based cohort, T<sub>2</sub> values were associated with BMI. Additionally, T<sub>2</sub> values in the lateral cartilage subregions were associated with MRI-based OA.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"34 2","pages":"Pages 232-239"},"PeriodicalIF":9.0,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145093532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Entheseal bone remodeling and patient reported outcomes in osteoarthritis – A quantitative [18F]NaF-PET MRI study 骨关节炎的骨骺骨重塑和患者报告的结果——一项定量[18F] nafpet MRI研究。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-18 DOI: 10.1016/j.joca.2025.09.008
Katharina Ziegeler , Virginie Kreutzinger , Lianne S. Gensler , Rupsa Bhattacharjee , Misung Han , Eric Hammond , Laura Chen , Emma Bahroos , Zehra Akkaya , Thomas M. Link , Richard B. Souza , Sharmila Majumdar

Objective

Entheses have been discussed as potential sources of pain in osteoarthritis (OA). Entheseal bone remodeling quantified by [18F]NaF-PET could be a surrogate marker for tensile forces causing a painful tissue response. This study aimed to investigate the relationship between [18 F]NaF-uptake, MRI findings and knee-related symptoms.

Method

Patients and healthy controls in this prospective observational study on patello-femoral OA (PFJOA) underwent simultaneous MR (at 3.0 T) and [18F]NaF PET imaging of both knees. Cartilage damage, subchondral marrow lesions, synovitis, and enthesophytes were semi-quantitatively assessed on MRI and entheseal tracer uptake was quantified in the anterior patella and tibial tuberosity. Symptoms were assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS). Generalized estimating equations were used to investigate associations between tracer uptake and symptoms; analyses were additionally adjusted for MRI-detected changes (as alternative symptom drivers), age, sex and body mass index.

Results

A total of 135 knees from 68 subjects were investigated (mean age 48.8 ± 10.4 years; 58.8% women). Higher [18F]NaF-uptake was significantly associated with worse outcomes for KOOS subscales sports (beta −2.7; p<0.001), quality of live (beta 3.0; p<0.001) and PFJ (beta 2.3; p=0.001), but not pain (beta −0.8; p=0.18), symptoms (beta −0.6; p=0.30) or activities of daily living (beta −1.1; p=0.06).

Conclusion

Entheseal bone remodeling quantified by [18F]NaF-PET-MRI is associated with patient-reported clinical knee outcomes. These findings underscore the potential of entheseal biology to inform the understanding of symptom generation in degenerative disease of the musculoskeletal system.
目的探讨骨关节炎(OA)疼痛的潜在来源。[18F]NaF-PET量化的骨骺骨重塑可以作为引起疼痛组织反应的拉力的替代标记物。本研究旨在探讨[18F] naf摄取、MRI表现与膝关节相关症状之间的关系。方法在本前瞻性观察研究中,患者和健康对照者同时对双膝进行MR (3.0T)和[18F]NaF PET成像。在MRI上对软骨损伤、软骨下骨髓病变、滑膜炎和内生菌进行半定量评估,对髌骨前和胫骨结节的内生示踪剂摄取进行定量评估。用膝关节损伤和骨关节炎结局评分(oos)评估症状。使用广义估计方程来研究示踪剂摄取与症状之间的关系;分析还针对mri检测到的变化(作为替代症状驱动因素)、年龄、性别和体重指数进行了调整。结果共调查68例患者135个膝关节(平均年龄48.8±10.4岁,女性58.8%)。较高的[18F]摄取与KOOS亚量表中较差的结果显著相关:运动(β -2.7, p<0.001)、生活质量(β - 3.0, p<0.001)和PFJ (β - 2.3, p=0.001),但与疼痛(β -0.8, p=0.18)、症状(β -0.6, p=0.30)或日常生活活动(β -1.1, p=0.06)无关。结论[18F]NaF-PET-MRI量化的骨骺骨重塑与患者报告的临床膝关节预后相关。这些发现强调了肌肉骨骼系统退行性疾病症状产生的理解的潜力。
{"title":"Entheseal bone remodeling and patient reported outcomes in osteoarthritis – A quantitative [18F]NaF-PET MRI study","authors":"Katharina Ziegeler ,&nbsp;Virginie Kreutzinger ,&nbsp;Lianne S. Gensler ,&nbsp;Rupsa Bhattacharjee ,&nbsp;Misung Han ,&nbsp;Eric Hammond ,&nbsp;Laura Chen ,&nbsp;Emma Bahroos ,&nbsp;Zehra Akkaya ,&nbsp;Thomas M. Link ,&nbsp;Richard B. Souza ,&nbsp;Sharmila Majumdar","doi":"10.1016/j.joca.2025.09.008","DOIUrl":"10.1016/j.joca.2025.09.008","url":null,"abstract":"<div><h3>Objective</h3><div>Entheses have been discussed as potential sources of pain in osteoarthritis (OA). Entheseal bone remodeling quantified by [18F]NaF-PET could be a surrogate marker for tensile forces causing a painful tissue response. This study aimed to investigate the relationship between [18 F]NaF-uptake, MRI findings and knee-related symptoms.</div></div><div><h3>Method</h3><div>Patients and healthy controls in this prospective observational study on patello-femoral OA (PFJOA) underwent simultaneous MR (at 3.0 T) and [18F]NaF PET imaging of both knees. Cartilage damage, subchondral marrow lesions, synovitis, and enthesophytes were semi-quantitatively assessed on MRI and entheseal tracer uptake was quantified in the anterior patella and tibial tuberosity. Symptoms were assessed with the Knee injury and Osteoarthritis Outcome Score (KOOS). Generalized estimating equations were used to investigate associations between tracer uptake and symptoms; analyses were additionally adjusted for MRI-detected changes (as alternative symptom drivers), age, sex and body mass index.</div></div><div><h3>Results</h3><div>A total of 135 knees from 68 subjects were investigated (mean age 48.8 ± 10.4 years; 58.8% women). Higher [18F]NaF-uptake was significantly associated with worse outcomes for KOOS subscales sports (beta −2.7; p&lt;0.001), quality of live (beta 3.0; p&lt;0.001) and PFJ (beta 2.3; p=0.001), but not pain (beta −0.8; p=0.18), symptoms (beta −0.6; p=0.30) or activities of daily living (beta −1.1; p=0.06).</div></div><div><h3>Conclusion</h3><div>Entheseal bone remodeling quantified by [18F]NaF-PET-MRI is associated with patient-reported clinical knee outcomes. These findings underscore the potential of entheseal biology to inform the understanding of symptom generation in degenerative disease of the musculoskeletal system.</div></div>","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":"33 12","pages":"Pages 1502-1510"},"PeriodicalIF":9.0,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145093493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to letter regarding 'A decade of exposure: Long-term air pollution and its impact on osteoarthritis: A nationwide cohort study in Taiwan'. 对“十年暴露:长期空气污染及其对骨关节炎的影响:台湾一项全国性队列研究”的回复。
IF 9 2区 医学 Q1 ORTHOPEDICS Pub Date : 2025-09-17 DOI: 10.1016/j.joca.2025.09.004
Yi-Chuan Chan, Yen-Wei Huang, Shu-Han Chuang, Yi-Jie Kuo, Yu-Pin Chen
{"title":"Response to letter regarding 'A decade of exposure: Long-term air pollution and its impact on osteoarthritis: A nationwide cohort study in Taiwan'.","authors":"Yi-Chuan Chan, Yen-Wei Huang, Shu-Han Chuang, Yi-Jie Kuo, Yu-Pin Chen","doi":"10.1016/j.joca.2025.09.004","DOIUrl":"10.1016/j.joca.2025.09.004","url":null,"abstract":"","PeriodicalId":19654,"journal":{"name":"Osteoarthritis and Cartilage","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145092240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Osteoarthritis and Cartilage
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1